nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-CD3 clinical trials in type 1 diabetes mellitus
|
Daifotis, Anastasia G. |
|
2013 |
149 |
3PA |
p. 268-278 11 p. |
artikel |
2 |
Anti-cytokine therapies in T1D: Concepts and strategies
|
Nepom, Gerald T. |
|
2013 |
149 |
3PA |
p. 279-285 7 p. |
artikel |
3 |
Biomarkers for immune intervention trials in type 1 diabetes
|
Mallone, Roberto |
|
2013 |
149 |
3PA |
p. 286-296 11 p. |
artikel |
4 |
Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform
|
Gottlieb, Peter |
|
2013 |
149 |
3PA |
p. 297-306 10 p. |
artikel |
5 |
DiaPep277® and immune intervention for treatment of type 1 diabetes
|
Schloot, Nanette C. |
|
2013 |
149 |
3PA |
p. 307-316 10 p. |
artikel |
6 |
Editorial Board
|
|
|
2013 |
149 |
3PA |
p. IFC- 1 p. |
artikel |
7 |
GLP-1 agonists in type 1 diabetes
|
Pettus, Jeremy |
|
2013 |
149 |
3PA |
p. 317-323 7 p. |
artikel |
8 |
IL-2 therapy in type 1 diabetes: “Trials” and tribulations
|
Long, S. Alice |
|
2013 |
149 |
3PA |
p. 324-331 8 p. |
artikel |
9 |
Keeping the patient perspective: Where are we in the world of type 1 diabetes?
|
Pettus, Jeremy |
|
2013 |
149 |
3PA |
p. 265-267 3 p. |
artikel |
10 |
Prevention versus intervention of type 1 diabetes
|
Brooks-Worrell, Barbara |
|
2013 |
149 |
3PA |
p. 332-338 7 p. |
artikel |
11 |
Targeting the trimolecular complex
|
Michels, Aaron W. |
|
2013 |
149 |
3PA |
p. 339-344 6 p. |
artikel |
12 |
Trials in type 1 diabetes: Antigen-specific therapies
|
Coppieters, Ken T. |
|
2013 |
149 |
3PA |
p. 345-355 11 p. |
artikel |